Investigating how SARS-CoV-2 enters human cells
Understand the mechanism of SARS-CoV-2 entry by single-molecule approaches
This study is looking at how the SARS-CoV-2 virus gets into our cells, which is important for creating better vaccines and treatments for COVID-19, and it's for anyone interested in understanding how we can fight this virus more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11183528 on NIH RePORTER |
What this research studies
This research focuses on understanding the mechanisms by which the SARS-CoV-2 virus enters human cells, which is crucial for developing effective vaccines and treatments. The study employs advanced techniques such as single-molecule fluorescence and magnetic tweezers to observe the interactions between the virus's spike protein and the ACE2 receptor on host cells. By analyzing these interactions at a molecular level, the research aims to uncover critical details about the virus's entry process and the role of neutralizing antibodies. This knowledge could lead to improved strategies for preventing and treating COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in contributing to the understanding of COVID-19 and its treatment, particularly those with a background in immunology or virology.
Not a fit: Patients who are not affected by COVID-19 or are not interested in the underlying mechanisms of viral entry may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines and therapeutics against COVID-19.
How similar studies have performed: Other research has shown success in understanding viral entry mechanisms, but this approach using single-molecule techniques is relatively novel.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Shrestha, Prakash — University of Kentucky
- Study coordinator: Shrestha, Prakash
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.